You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR SODIUM AMINOSALICYLATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SODIUM AMINOSALICYLATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03830671 ↗	The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB	Recruiting	Beijing Chest Hospital	N/A	2019-03-08	WHO has recommended that multidrug-resistant tuberculosis (MDR-TB, defined as resistance to at least isoniazid (H) and rifampicin (R) be addressed as a public health crisis and enhance capacity to deliver effective treatment and care. According to the 2018 WHO TB Report, the overall treatment success rate of MDR-TB is 55% while much lower in China at just only 41% with the 24-month regimen. In order to further verify the safety and efficiency of optimizing shorter 18-month regimen containing 6 anti-TB drugs with MDR-TB patients,500 more patients will be enrolled and observed.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SODIUM AMINOSALICYLATE

Condition Name

Chart
Table

Condition Name for SODIUM AMINOSALICYLATE
Intervention	Trials
Multi-drug Resistant Tuberculosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SODIUM AMINOSALICYLATE
Intervention	Trials
Tuberculosis	1
Tuberculosis, Multidrug-Resistant	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SODIUM AMINOSALICYLATE

Trials by Country

Map
Table

Trials by Country for SODIUM AMINOSALICYLATE
Location	Trials
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SODIUM AMINOSALICYLATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SODIUM AMINOSALICYLATE
Clinical Trial Phase	Trials
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SODIUM AMINOSALICYLATE
Clinical Trial Phase	Trials
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SODIUM AMINOSALICYLATE

Sponsor Name

Chart
Table

Sponsor Name for SODIUM AMINOSALICYLATE
Sponsor	Trials
Beijing Chest Hospital	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SODIUM AMINOSALICYLATE
Sponsor	Trials
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.